Erwin Birnie

Dr. Erwin Birnie is a Lecturer at the Erasmus School of Health Policy & Management, specializing in Health Technology Assessment (HTA) at Erasmus University Rotterdam. His research focuses on healthcare economics, surgical outcomes, and diabetes biomarkers. He has led and contributed to 116 peer-reviewed publications, including randomized controlled trials and cohort studies.

Key research areas include cost-effectiveness analysis of colorectal surgery interventions, perioperative music therapy, and biomarker studies in type 1 diabetes. He has collaborated on national cohort initiatives like the 'Biomarkers of Heterogeneity in Type 1 Diabetes' study.

His work emphasizes practical healthcare improvements, such as optimizing IBD care pathways and evaluating healthcare cost variations between hospitals. He has supervised two academic projects and contributed to datasets like the 'Discriminative power of the ReproQ' (2020).